13D Filing: Tang Capital Partners LP and Odonate Therapeutics Inc (ODT)

Page 11 of 14

Page 11 of 14 – SEC Filing

EXHIBIT 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value $0.01, of Odonate Therapeutics, Inc., and that this Agreement be included as an Exhibit to such joint filing. The Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument.
IN WITNESS WHEREOF, the undersigned hereby execute this Agreement this 18th day of December, 2017.
Tang Capital Partners, LP
By:
Tang Capital Management, LLC
By:
/s/ Kevin C. Tang
Kevin C. Tang, Manager
Tang Capital Management, LLC
By:
/s/ Kevin C. Tang
Kevin C. Tang, Manager
/s/ Kevin C. Tang
Kevin C. Tang

Follow Odonate Therapeutics Inc. (NASDAQ:ODT)

Page 11 of 14